Tredaptive, Cholesterol Drug, Withdrawn Worldwide By Merck

Drugmaker Withdraws Cholesterol Drug Worldwide

Jan 11 (Reuters) - Merck & Co Inc said it would withdraw its cholesterol drug Tredaptive from markets worldwide after European regulators recommended that marketing of the drug be suspended.

The drug was under review in Europe after the failure of a major study raised safety concerns.

Merck recommended that physicians stop prescribing the drug and review treatment plans for patients taking it.

Before You Go

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE